WebMar 3, 2024 · atai Life Sciences. Mar 03, 2024, 08:00 ET. NEW YORK, March 3, 2024 /PRNewswire/ -- atai Life Sciences ("atai" or the "Company"), a clinical-stage biopharmaceutical company developing psychedelic ...

Atai Life Sciences N.V.: A First Take - SeekingAlpha

WebJan 27, 2024 · atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2024 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to acquiring, incubating and efficiently developing innovative therapeutics to ... WebOct 30, 2024 · At Compass’ current market cap of ~$1.1 billion, ATAI has a $200 – 300 million stake in the company. This gives ATAI’s valuation a sort of floor dependent on Compass’ ultimate market cap. It will be just as important for Compass to succeed over the coming months as it will for ATAI’s portfolio companies to perform. marian neville

ATAI Due Diligence : r/shroomstocks - Reddit

WebMar 15, 2024 · atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2024 as a response to the … WebMar 22, 2024 · NEW YORK and BERLIN, Jan. 06, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a…. January 9, 2024. 9:00 am. … Note: DMT = N,N-dimethyltryptamine; MDMA = 3,4-Methyl enedioxy … Receive the latest news on atai and innovations in the space. Email. Mission … atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) … Its mission is an extension of atai Life Sciences’ vision: to heal mental health … Psilocybin Watts et al., “Patients’ Accounts of Increased ‘Connectedness’ and … WebSep 23, 2024 · The results showed that the five-item ATAI scale comprises two negatively associated factors assessing (1) acceptance and (2) fear of artificial intelligence. The … marianne ventura